Tokyo, Japan

Shigeru Noguchi

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Shigeru Noguchi: Innovator in Antibody-Drug Conjugate Technology

Introduction

Shigeru Noguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antibody-drug conjugates. With a total of 14 patents to his name, Noguchi's work has had a substantial impact on drug development and therapeutic applications.

Latest Patents

Among his latest patents, Noguchi has developed methods for producing antibody-drug conjugates. One notable patent details a method for producing crystals of a compound represented by a specific formula, along with a method for producing an antibody-drug conjugate using these crystals. Another patent outlines a method for producing a compound where an amino group is protected with a protecting group, involving intramolecular cyclization to convert the compound into a desired form.

Career Highlights

Throughout his career, Shigeru Noguchi has worked with leading pharmaceutical companies, including Daiichi Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited. His expertise in drug formulation and development has positioned him as a key figure in the industry.

Collaborations

Noguchi has collaborated with notable colleagues such as Shinji Kamihara and Kazuaki Kanai. Their combined efforts have contributed to advancements in the field of antibody-drug conjugates.

Conclusion

Shigeru Noguchi's innovative work in the pharmaceutical industry, particularly in antibody-drug conjugate technology, showcases his dedication to advancing medical science. His numerous patents reflect his commitment to improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…